Abstract
Background The ability to obtain adequate staff, supplies, structures, and systems to provide sufficient care to meet the immediate needs of an influx of patients is defined as surge capacity. The research aimed to describe the surge capacity of curative-healthcare institutions for disaster management at disease endemic district of Sri Lanka.
Methods From May to September 2019, a descriptive cross-sectional study was conducted among all curative-healthcare institutions (n=46) with inward-care facilities for patient care in the Kurunegala district, Sri Lanka. The ’Science of Surge Theory’ was used to develop an interviewer-administered tool. The medical administrator of the institution collected the data from a designated employee for disaster management in the institution. For the criteria of overall surge capacity for medical disaster management, the levels have been categorized as basic (26-50%), moderate (51-75%), and high (>75%).
Results Response-rate was 93.5% (n=43). The higher proportion of the institutions had (55.8%; n=24), inadequate staff capacity, and lack of equipment. Of the equipped institutions, 13.3% (n=4), 38.7% (n=12), 40.9% (n=9), and 30.2% (n=13) had an adequate number of adjustable beds, infusion pumps, saturation monitors, and oxygen cylinders, respectively. The higher proportion of the institutions had designated emergency treatment units (90.7%; n=39). The least proportion of the institutions had X-ray services (11.6%, n=5), Ultrasound (USS) (9.3%; n=4) and blood bank services (9.3%; n=4). The higher proportion (69.8%; n=30) had inadequate overall surge capacity. The Provincial General Hospitals and 75% (n=3) of the Base-hospitals had moderate-level and higher proportion of the District Hospitals (76.3%; n=29) had basic level overall surge capacity for disaster management.
Conclusion The overall surge capacity was inadequate and there is a need for improvement of surge capacity of the curative-healthcare institutions in the district for disease outbreak management. The capacity development programmes need to be initiated to improve the preparedness.
What is already known on this topic
Surge capacity refers to a healthcare system’s ability to respond to a sudden increase in patient care demands. Furthermore, surge capacity is a measurable representation of ability to manage a sudden influx of patients following emergencies and it depends on a well-functioning incident management system. The capacity assessments are more important than encouraging stakeholders for management during response. Therefore, capacity assessment and outbreak response planning should be aligned as a measure of outbreak preparedness.
What this study adds
The research aimed to describe the surge capacity of curative-healthcare institutions for disaster management following a disease epidemic in a disease-endemic major district of Sri Lanka. The overall surge capacity was inadequate and there is a need for improvement of surge capacity of the curative-healthcare institutions in the district for disease outbreak management. The capacity development programmes need to be initiated to improve the preparedness to face future epidemics/disasters.
How this study might affect research, practice or policy
The results of this study have many implications for practice, education, and research. With improving need of the rising population, there is increased risk of disasters including disease outbreaks. During such situations, healthcare institutions need to play a significant role. Assessing the surge capacity is the first step to obtaining baseline data about their capacity to respond to future disasters in their institutions. The findings of this study have determined critical areas of adequacy of staff, disaster planning and preparedness, adequacy of equipment, services, availability of guidelines, capabilities of risk communication to address the needs of healthcare providers in public sector institution for efficient and timely disaster response.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any specific grant from funding agencies for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
